Aug 02, 2023 7:00am EDT Matinas BioPharma to Participate in the BTIG Virtual Biotechnology Conference 2023
Jul 26, 2023 8:00am EDT Matinas BioPharma to Webcast Conference Call to Discuss Second Quarter 2023 Financial Results and Provide a Business Update on August 9, 2023
May 11, 2023 7:30am EDT Matinas BioPharma to Present at the JMP Securities Life Sciences Conference on May 15, 2023
May 10, 2023 4:05pm EDT Matinas BioPharma Reports First Quarter 2023 Financial Results and Provides a Business Update
May 03, 2023 7:00am EDT Matinas BioPharma to Webcast Conference Call to Discuss First Quarter 2023 Financial Results and Provide a Business Update on May 10, 2023
Apr 18, 2023 8:00am EDT Compassionate Use Patient Treated with Matinas BioPharma’s MAT2203 and Showing Complete Clinical Resolution of Rare R. mucilaginosa Fungal Infection Featured in Oral Presentation at ECCMID
Mar 15, 2023 4:05pm EDT Matinas BioPharma Reports 2022 Financial Results and Provides a Business Update
Mar 08, 2023 7:00am EST Matinas BioPharma to Webcast Conference Call to Discuss 2022 Financial Results and Provide a Business Update on March 15, 2023
Mar 02, 2023 7:00am EST Matinas BioPharma Announces that MAT2203 Will Be Featured in Two Oral Presentations at ECCMID
